{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:02:07Z","timestamp":1791064927510,"version":"4.1.0"},"reference-count":289,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.pharmthera.2011.06.008","type":"journal-article","created":{"date-parts":[[2011,8,3]],"date-time":"2011-08-03T13:25:29Z","timestamp":1312377929000},"page":"1-18","source":"Crossref","is-referenced-by-count":128,"title":["Targeting chemokine receptors in chronic inflammatory diseases: An extensive review"],"prefix":"10.1016","volume":"133","author":[{"given":"Pim J.","family":"Koelink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia A.","family":"Overbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Braber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"de Kruijf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Folkerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine J.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aletta D.","family":"Kraneveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0005","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.atherosclerosis.2009.08.017","article-title":"CCR2 receptor blockade alters blood monocyte subpopulations but does not affect atherosclerotic lesions in apoE(\u2212\/\u2212) mice","volume":"208","author":"Aiello","year":"2010","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2567.2002.01309.x","article-title":"Role of chemokines and chemokine receptors in the gastrointestinal tract","volume":"105","author":"Ajuebor","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.pharmthera.2011.06.008_bb0015","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1146\/annurev.immunol.24.021605.090529","article-title":"Chemokine: receptor structure, interactions, and antagonism","volume":"25","author":"Allen","year":"2007","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"10.1016\/j.pharmthera.2011.06.008_bb0020","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/1521-4141(200208)32:8<2133::AID-IMMU2133>3.0.CO;2-W","volume":"32","author":"Alt","year":"2002","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb0025","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1751-2980.2008.00336.x","article-title":"Neutrophil chemokines GCP-2 and GRO-alpha in patients with inflammatory bowel disease","volume":"9","author":"Alzoghaibi","year":"2008","journal-title":"J Dig Dis"},{"key":"10.1016\/j.pharmthera.2011.06.008_bb0030","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/sj.bjp.0706912","article-title":"Pharamacological blockade of CCR1 ameliorates murine arthritis and alters cytokine networks in vivo","volume":"149","author":"Amat","year":"2006","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.pharmthera.2011.06.008_bb0035","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1023\/B:NERE.0000021246.96864.89","article-title":"Chemokines and glial cells: a complex network in the central nervous system","volume":"29","author":"Ambrosini","year":"2004","journal-title":"Neurochem Res"},{"issue":"12","key":"10.1016\/j.pharmthera.2011.06.008_bb0040","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.4049\/jimmunol.164.12.6303","article-title":"Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine","volume":"164","author":"Andres","year":"2000","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.pharmthera.2011.06.008_bb0045","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/01.ATV.16.8.1007","article-title":"Interleukin-8 production by macrophages from atheromatous plaques","volume":"16","author":"Apostolopoulos","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.pharmthera.2011.06.008_bb0050","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.1073\/pnas.96.12.6873","article-title":"CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions","volume":"96","author":"Balashov","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.pharmthera.2011.06.008_bb0055","first-page":"1279","article-title":"The Th1 immune pathway as a therapeutic target in crohn's disease","volume":"4","author":"Bamias","year":"2003","journal-title":"Curr Opin Investig Drugs"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0060","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/path.1245","article-title":"Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease","volume":"199","author":"Banks","year":"2003","journal-title":"J Pathol"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1056\/NEJM200007273430407","article-title":"Chronic obstructive pulmonary disease","volume":"343","author":"Barnes","year":"2000","journal-title":"N Engl J Med"},{"issue":"2 Suppl.","key":"10.1016\/j.pharmthera.2011.06.008_bb0070","doi-asserted-by":"crossref","first-page":"10S","DOI":"10.1378\/chest.117.2_suppl.10S","article-title":"Mechanisms in COPD: differences from asthma","volume":"117","author":"Barnes","year":"2000","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb0075","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1124\/pr.56.4.2","article-title":"Mediators of chronic obstructive pulmonary disease","volume":"56","author":"Barnes","year":"2004","journal-title":"Pharmacol Rev"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nri2254","article-title":"Immunology of asthma and chronic obstructive pulmonary disease","volume":"8","author":"Barnes","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb0085","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1183\/09031936.03.00040703","article-title":"Chronic obstructive pulmonary disease: molecular and cellular mechanisms","volume":"22","author":"Barnes","year":"2003","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1468-1331.2004.00951.x","article-title":"The levels of chemokines CXCL8, CCL2 and CCL5 in multiple sclerosis patients are linked to the activity of the disease","volume":"12","author":"Bartosik-Psujek","year":"2005","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb0095","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1189\/jlb.0408231","article-title":"The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice","volume":"84","author":"Bento","year":"2008","journal-title":"J Leukoc Biol"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0100","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s10875-007-9142-7","article-title":"Treatment of multiple sclerosis with methylprednisolone and mitoxantrone modulates the expression of CXC chemokine receptors in PBMC","volume":"28","author":"Bielecki","year":"2008","journal-title":"J Clin Immunol"},{"issue":"14","key":"10.1016\/j.pharmthera.2011.06.008_bb0105","doi-asserted-by":"crossref","first-page":"8080","DOI":"10.1073\/pnas.96.14.8080","article-title":"IL-4 enhances proliferation and mediator release in mature human mast cells","volume":"96","author":"Bischoff","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pharmthera.2006.04.002","article-title":"ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets","volume":"112","author":"Bizzarri","year":"2006","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00000372-199504000-00005","article-title":"A subset of macrophages located along the basement membrane (\u201clining cells\u201d) is a characteristic histopathological feature of psoriasis","volume":"17","author":"Boehncke","year":"1995","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb0120","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2353\/ajpath.2006.040748","article-title":"Up-regulated expression of the CXCR2 ligand KC\/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression","volume":"168","author":"Boisvert","year":"2006","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0125","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1172\/JCI1195","article-title":"A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice","volume":"101","author":"Boisvert","year":"1998","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.pharmthera.2011.06.008_bb0130","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1080\/08916930802095210","article-title":"Gene expression profiles at different stages of collagen-induced arthritis","volume":"41","author":"Booth","year":"2008","journal-title":"Autoimmunity"},{"issue":"6696","key":"10.1016\/j.pharmthera.2011.06.008_bb0135","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/29788","article-title":"Decreased lesion formation in CCR2\u2212\/\u2212 mice reveals a role for chemokines in the initiation of atherosclerosis","volume":"394","author":"Boring","year":"1998","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.pharmthera.2011.06.008_bb0140","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nri1132","article-title":"The immunological and genetic basis of inflammatory bowel disease","volume":"3","author":"Bouma","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.pharmthera.2011.06.008_bb0145","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1164\/ajrccm.161.5.9903102","article-title":"Asthma. From bronchoconstriction to airways inflammation and remodeling","volume":"161","author":"Bousquet","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0150","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2249.2000.01334.x","article-title":"Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions","volume":"122","author":"Boven","year":"2000","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0155","doi-asserted-by":"crossref","first-page":"L255","DOI":"10.1152\/ajplung.00304.2010","article-title":"Cigarette smoke-induced lung emphysema in mice is associated with prolyl endopeptidase, an enzyme involved in collagen breakdown","volume":"300","author":"Braber","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2011.06.008_bb0160","unstructured":"Braber, S., Overbeek, S. A., Koelink, P. J., Henricks, P. A., Zaman, G. J., Garssen, J., et al. (in press). CXCR2 antagonists block the N-ac-PGP-induced neutrophil influx in the airways of mice, but not the production of the chemokine CXCL1. Eur J Pharmacol."},{"key":"10.1016\/j.pharmthera.2011.06.008_bb0165","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1111\/j.1365-2222.2007.02808.x","article-title":"Cigarette smoke-induced pulmonary inflammation, but not airway remodelliing is attenuated in chemokine receptor 5-deficient mice","volume":"37","author":"Bracke","year":"2007","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb0170","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaci.2006.02.039","article-title":"The role of the mast cell in the pathophysiology of asthma","volume":"117","author":"Bradding","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.pharmthera.2011.06.008_bb0175","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1160\/TH07-01-0036","article-title":"The specific role of chemokines in atherosclerosis","volume":"97","author":"Braunersreuther","year":"2007","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0180","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/01.ATV.0000253886.44609.ae","article-title":"Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice","volume":"27","author":"Braunersreuther","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0185","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/cvr\/cvq044","article-title":"Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation","volume":"86","author":"Breland","year":"2010","journal-title":"Cardiovasc Res"},{"issue":"5262","key":"10.1016\/j.pharmthera.2011.06.008_bb0190","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1126\/science.272.5262.685","article-title":"Mouse models of atherosclerosis","volume":"272","author":"Breslow","year":"1996","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.pharmthera.2011.06.008_bb0195","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1164\/rccm.200409-1220OC","article-title":"The CXCL10\/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle","volume":"171","author":"Brightling","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.pharmthera.2011.06.008_bb0200","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1189\/jlb.0904511","article-title":"Differential expression of CCR3 and CXCR3 by human lung and bone marrow-derived mast cells: implications for tissue mast cell migration","volume":"77","author":"Brightling","year":"2005","journal-title":"J Leukoc Biol"},{"issue":"8","key":"10.1016\/j.pharmthera.2011.06.008_bb0205","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.4049\/jimmunol.175.8.5370","article-title":"Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344","volume":"175","author":"Brodmerkel","year":"2005","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.pharmthera.2011.06.008_bb0210","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1189\/jlb.0207118","article-title":"Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice","volume":"82","author":"Buanne","year":"2007","journal-title":"J Leukoc Biol"},{"issue":"12","key":"10.1016\/j.pharmthera.2011.06.008_bb0215","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/rheumatology\/keg413","article-title":"Michael Mason Prize Essay 2003. Why do leucocytes accumulate within chronically inflamed joints?","volume":"42","author":"Buckley","year":"2003","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.pharmthera.2011.06.008_bb0220","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1084\/jem.20052144","article-title":"A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development","volume":"203","author":"Burns","year":"2006","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb0225","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/08916930802629547","article-title":"An antibody to IP-10 is a potent antagonist of cell migration in vitro and in vivo and does not affect disease in several animal models of inflammation","volume":"42","author":"Byrne","year":"2009","journal-title":"Autoimmunity"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb0230","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.4049\/jimmunol.163.4.2160","article-title":"Monocyte chemoattractant protein-1 mediates cockroach allergen-induced bronchial hyperreactivity in normal but not CCR2\u2212\/\u2212 mice: the role of mast cells","volume":"163","author":"Campbell","year":"1999","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb0235","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/01.bor.0000129715.35024.50","article-title":"Psoriasis vulgaris: an interplay of T lymphocytes, dendritic cells, and inflammatory cytokines in pathogenesis","volume":"16","author":"Chamian","year":"2004","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb0240","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation","volume":"354","author":"Charo","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0245","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00403-009-0966-2","article-title":"Expression of chemokine receptor CXCR3 by lymphocytes and plasmacytoid dendritic cells in human psoriatic lesions","volume":"302","author":"Chen","year":"2010","journal-title":"Arch Dermatol Res"},{"issue":"8","key":"10.1016\/j.pharmthera.2011.06.008_bb0250","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.4049\/jimmunol.0900525","article-title":"Overexpression of CXC chemokine ligand 14 exacerbates collagen-induced arthritis","volume":"184","author":"Chen","year":"2010","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.pharmthera.2011.06.008_bb0255","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1084\/jem.193.5.573","article-title":"Aberrant in vivo T helper type 2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout mice","volume":"193","author":"Chensue","year":"2001","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.pharmthera.2011.06.008_bb0260","doi-asserted-by":"crossref","first-page":"R188","DOI":"10.1186\/ar3158","article-title":"CXC chemokine receptor 4 expressed in T cells plays an important role in the development of collagen-induced arthritis","volume":"12","author":"Chung","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.pharmthera.2011.06.008_bb0265","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1161\/01.CIR.0000057548.68243.42","article-title":"Decreased atherosclerotic lesion formation in CX3CR1\/apolipoprotein E double knockout mice","volume":"107","author":"Combadiere","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0270","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1378\/chest.07-0393","article-title":"CXCR3 and CCR5 chemokines in induced sputum from patients with COPD","volume":"133","author":"Costa","year":"2008","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb0275","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10875-008-9236-x","article-title":"Multiple sclerosis and regulatory T cells","volume":"28","author":"Costantino","year":"2008","journal-title":"J Clin Immunol"},{"issue":"10","key":"10.1016\/j.pharmthera.2011.06.008_bb0280","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/jcp.2005.030916","article-title":"Chemokines in inflammatory bowel disease","volume":"58","author":"Danese","year":"2005","journal-title":"J Clin Pathol"},{"issue":"5","key":"10.1016\/j.pharmthera.2011.06.008_bb0285","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/(SICI)1096-9896(200004)190:5<619::AID-PATH555>3.0.CO;2-6","article-title":"Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD","volume":"190","author":"de Boer","year":"2000","journal-title":"J Pathol"},{"issue":"7","key":"10.1016\/j.pharmthera.2011.06.008_bb0290","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00403-007-0764-7","article-title":"Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor","volume":"299","author":"de Groot","year":"2007","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0295","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1124\/jpet.108.148387","article-title":"Nonpeptidergic allosteric antagonists differentially bind to the CXCR2 chemokine receptor","volume":"329","author":"de Kruijf","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0300","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/03009749409102126","article-title":"Localisation of interleukin 8 in the synovial membrane, cartilage\u2013pannus junction and chondrocytes in rheumatoid arthritis","volume":"23","author":"Deleuran","year":"1994","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0305","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1084\/jem.188.2.373","article-title":"Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites","volume":"188","author":"Dieu","year":"1998","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.pharmthera.2011.06.008_bb0310","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.192.5.705","article-title":"Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting langerhans cell precursors","volume":"192","author":"Dieu-Nosjean","year":"2000","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.pharmthera.2011.06.008_bb0315","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.tips.2006.08.001","article-title":"Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease","volume":"27","author":"Donnelly","year":"2006","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb0320","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ibd.21106","article-title":"CXCL12 is a constitutive and inflammatory chemokine in the intestinal immune system","volume":"16","author":"Dotan","year":"2010","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb0325","first-page":"245","article-title":"Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints","volume":"10","author":"Endo","year":"1991","journal-title":"Lymphokine Cytokine Res"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0330","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1124\/jpet.108.145862","article-title":"Therapeutic effect of blocking CXCR2 on neutrophil recruitment and dextran sodium sulfate-induced colitis","volume":"329","author":"Farooq","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"10.1016\/j.pharmthera.2011.06.008_bb0335","doi-asserted-by":"crossref","first-page":"7617","DOI":"10.4049\/jimmunol.166.12.7617","article-title":"CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis","volume":"166","author":"Fife","year":"2001","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb0340","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.tips.2008.01.005","article-title":"New endogenous CXC chemokine ligands as potential targets in lung emphysema","volume":"29","author":"Folkerts","year":"2008","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb0345","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/rr85","article-title":"The role of collagenase in emphysema","volume":"2","author":"Foronjy","year":"2001","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb0350","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1183\/09031936.05.00047504","article-title":"Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease","volume":"25","author":"Fujimoto","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmthera.2011.06.008_bb0355","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.21.120601.141025","article-title":"Mast cells as \u201ctunable\u201d effector and immunoregulatory cells: recent advances","volume":"23","author":"Galli","year":"2005","journal-title":"Annu Rev Immunol"},{"issue":"3 Suppl. 2","key":"10.1016\/j.pharmthera.2011.06.008_bb0360","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jaad.2005.10.057","article-title":"Innate and adaptive immunity and the pathophysiology of psoriasis","volume":"54","author":"Gaspari","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.pharmthera.2011.06.008_bb0365","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1002\/art.27652","article-title":"Preclinical and clinical investigation of a CCR5 antagonist, AZD5672, in patients with rheumatoid arthritis receiving methotrexate","volume":"62","author":"Gerlag","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb0370","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.amjcard.2010.11.005","article-title":"Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region","volume":"107","author":"Gilbert","year":"2011","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.pharmthera.2011.06.008_bb0375","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1067\/mai.2001.114707","article-title":"Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines","volume":"107","author":"Giustizieri","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pharmthera.2011.06.008_bb0380","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0076-6879(97)88015-9","article-title":"Murine experimental autoimmune encephalomyelitis: a model of immune-mediated inflammation and multiple sclerosis","volume":"288","author":"Glabinski","year":"1997","journal-title":"Methods Enzymol"},{"issue":"5","key":"10.1016\/j.pharmthera.2011.06.008_bb0385","first-page":"499","article-title":"CCR1 antagonists for the treatment of autoimmune diseases","volume":"5","author":"Gladue","year":"2004","journal-title":"Curr Opin Investig Drugs"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb0390","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","article-title":"Atherosclerosis. The road ahead","volume":"104","author":"Glass","year":"2001","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0395","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1084\/jem.186.1.131","article-title":"An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model","volume":"186","author":"Gong","year":"1997","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb0400","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/01.ATV.21.6.923","article-title":"Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions","volume":"21","author":"Greaves","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0405","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1097-2765(00)80139-2","article-title":"Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice","volume":"2","author":"Gu","year":"1998","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0410","first-page":"7","article-title":"Overlap of asthma and chronic obstructive pulmonary disease","volume":"11","author":"Guerra","year":"2005","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb0415","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1189\/jlb.0108061","article-title":"An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo","volume":"84","author":"Handel","year":"2008","journal-title":"J Leukoc Biol"},{"issue":"7","key":"10.1016\/j.pharmthera.2011.06.008_bb0420","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pharmthera.2011.06.008_bb0425","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.pathol.1.110304.100100","article-title":"Inflammation and atherosclerosis","volume":"1","author":"Hansson","year":"2006","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"10.1016\/j.pharmthera.2011.06.008_bb0430","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/jlb.56.5.559","article-title":"Essential involvement of interleukin-8 (IL-8) in acute inflammation","volume":"56","author":"Harada","year":"1994","journal-title":"J Leukoc Biol"},{"issue":"8","key":"10.1016\/j.pharmthera.2011.06.008_bb0435","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/art.21975","article-title":"A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis","volume":"54","author":"Haringman","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb0440","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/ard.2005.037176","article-title":"Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis","volume":"65","author":"Haringman","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.pharmthera.2011.06.008_bb0445","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/jid.2009.65","article-title":"Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis","volume":"129","author":"Harper","year":"2009","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.pharmthera.2011.06.008_bb0450","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jaci.2007.02.023","article-title":"Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma","volume":"119","author":"Hartl","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.pharmthera.2011.06.008_bb0455","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.4049\/jimmunol.181.11.8053","article-title":"Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases","volume":"181","author":"Hartl","year":"2008","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.pharmthera.2011.06.008_bb0460","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1172\/JCI37378","article-title":"CCR6 is required for IL-23-induced psoriasis-like inflammation in mice","volume":"119","author":"Hedrick","year":"2009","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb0465","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.pharmthera.2005.02.006","article-title":"The therapeutic potential in targeting CCR5 and CXCR4 receptors in infectious and allergic pulmonary disease","volume":"107","author":"Hogaboam","year":"2005","journal-title":"Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb0470","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1183\/09031936.00048509","article-title":"SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects","volume":"35","author":"Holz","year":"2010","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0475","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nm0202-157","article-title":"CCL27\u2013CCR10 interactions regulate T cell-mediated skin inflammation","volume":"8","author":"Homey","year":"2002","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.pharmthera.2011.06.008_bb0480","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.4049\/jimmunol.164.12.6621","article-title":"Up-regulation of macrophage inflammatory protein-3 alpha\/CCL20 and CC chemokine receptor 6 in psoriasis","volume":"164","author":"Homey","year":"2000","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.pharmthera.2011.06.008_bb0485","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.clindermatol.2007.11.003","article-title":"Chemokines and other mediators as therapeutic targets in psoriasis vulgaris","volume":"26","author":"Homey","year":"2008","journal-title":"Clin Dermatol"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb0490","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1359-6101(01)00014-4","article-title":"Chemokine receptors","volume":"12","author":"Horuk","year":"2001","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0495","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrd2734","article-title":"Chemokine receptor antagonists: overcoming developmental hurdles","volume":"8","author":"Horuk","year":"2009","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb0500","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.193.6.713","article-title":"Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis","volume":"193","author":"Huang","year":"2001","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.pharmthera.2011.06.008_bb0505","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0167-5699(99)01535-2","article-title":"The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences","volume":"20","author":"Humbert","year":"1999","journal-title":"Immunol Today"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0510","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1043-4666(02)00493-3","article-title":"Chemokine\/chemokine receptor nomenclature","volume":"21","author":"IUIS\/WHO Subcommittee on Chemokine Nomenclature","year":"2003","journal-title":"Cytokine"},{"issue":"18","key":"10.1016\/j.pharmthera.2011.06.008_bb0515","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1111\/j.1742-4658.2008.06580.x","article-title":"Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients","volume":"275","author":"Iwamoto","year":"2008","journal-title":"FEBS J"},{"issue":"7","key":"10.1016\/j.pharmthera.2011.06.008_bb0520","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.192.7.1075","article-title":"Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2","volume":"192","author":"Izikson","year":"2000","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb0525","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3109\/00365529309090244","article-title":"Neutrophil-activating peptide (interleukin-8) in colonic mucosa from patients with crohn's disease","volume":"28","author":"Izzo","year":"1993","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"10.1016\/j.pharmthera.2011.06.008_bb0530","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/art.27470","article-title":"Deficiency of CXCR@, but not other chemoki9ne receptors, attenuates autoantibody-mediated arthritis in a murine model","volume":"62","author":"Jacobs","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pharmthera.2011.06.008_bb0535","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1002\/stem.222","article-title":"CXCR2 mediates the recruitment of endothelial progenitor cells during allergic airways remodeling","volume":"27","author":"Jones","year":"2009","journal-title":"Stem Cells"},{"issue":"12","key":"10.1016\/j.pharmthera.2011.06.008_bb0540","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1002\/1521-4141(200012)30:12<3614::AID-IMMU3614>3.0.CO;2-B","article-title":"The chemokine receptor CXCR4 is expressed within the mast cell lineage and its ligand stromal cell-derived factor-1alpha acts as a mast cell chemotaxin","volume":"30","author":"Juremalm","year":"2000","journal-title":"Eur J Immunol"},{"issue":"10","key":"10.1016\/j.pharmthera.2011.06.008_bb0545","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.4049\/jimmunol.155.10.5003","article-title":"An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis","volume":"155","author":"Karpus","year":"1995","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0550","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1023\/B:JOCI.0000018066.46279.6b","article-title":"Increased expression of CCL20 in human inflammatory bowel disease","volume":"24","author":"Kaser","year":"2004","journal-title":"J Clin Immunol"},{"issue":"5","key":"10.1016\/j.pharmthera.2011.06.008_bb0555","doi-asserted-by":"crossref","first-page":"G1263","DOI":"10.1152\/ajpgi.00409.2006","article-title":"MIP-3alpha neutralizing monoclonal antibody protects against TNBS-induced colonic injury and inflammation in mice","volume":"292","author":"Katchar","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0560","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJM200101043440106","article-title":"Allergy and allergic diseases. first of two parts","volume":"344","author":"Kay","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0565","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1164\/ajrccm.153.2.8564092","article-title":"Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma","volume":"153","author":"Keatings","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb0570","doi-asserted-by":"crossref","first-page":"L584","DOI":"10.1152\/ajplung.00453.2003","article-title":"The chemokine receptor CXCR3 and its splice variant are expressed in human airway epithelial cells","volume":"287","author":"Kelsen","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0575","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.expneurol.2009.07.010","article-title":"Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis","volume":"220","author":"Kerstetter","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pharmthera.2011.06.008_bb0580","series-title":"Digestive Disease Week, New Orleans, Louisiana, USA, May 1\u20135 2010 Abstract #647","article-title":"Chemokine receptor Antagonist CCX282-B (Traficet-En\u2122) Maintained Remission in Crohn's Disease in PROTECT-1 Study","author":"Keshav","year":"2010"},{"issue":"9","key":"10.1016\/j.pharmthera.2011.06.008_bb0585","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1172\/JCI13543","article-title":"Rules of chemokine receptor association with T cell polarization in vivo","volume":"108","author":"Kim","year":"2001","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb0590","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.4049\/jimmunol.1001156","article-title":"CCR6 marks regulatory T cells as a colon-tropic, IL-10-producing phenotype","volume":"185","author":"Kitamura","year":"2010","journal-title":"J Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2011.06.008_bb0595","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1038\/mi.2008.51","article-title":"Regulatory T cells and the induction of IL-17","volume":"1","author":"Kitani","year":"2008","journal-title":"Mucosal Immunol"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0600","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4049\/jimmunol.172.1.550","article-title":"IFN-inducible protein 10\/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis","volume":"172","author":"Klein","year":"2004","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.pharmthera.2011.06.008_bb0605","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ibd.20113","article-title":"Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes","volume":"13","author":"Kobayashi","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb0610","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/art.20932","article-title":"Chemokines and their receptors in rheumatoid arthritis: future targets?","volume":"52","author":"Koch","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb0615","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1172\/JCI115950","article-title":"Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis","volume":"90","author":"Koch","year":"1992","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb0620","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng.583","article-title":"A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility","volume":"42","author":"Kochi","year":"2010","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb0625","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1517\/14728220902762928","article-title":"CCR9 and inflammatory bowel disease","volume":"13","author":"Koenecke","year":"2009","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0630","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nm.1898","article-title":"Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice","volume":"15","author":"Koenen","year":"2009","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0635","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1189\/jlb.1109768","article-title":"Crucial involvement of the CX3CR1\u2013CX3CL1 axis in dextran sulfate sodium-mediated acute colitis in mice","volume":"88","author":"Kostadinova","year":"2010","journal-title":"J Leukoc Biol"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0640","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/ar141","article-title":"The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8)","volume":"3","author":"Kraan","year":"2001","journal-title":"Arthritis Res"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0645","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3899\/jrheum.090769","article-title":"CXCL 9 and CXCL 10 as sensitive markers of disease activity in patients with rheumatoid arthritis","volume":"37","author":"Kuan","year":"2010","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0650","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1523-1747.1998.00074.x","article-title":"The CXC receptor 2 is overexpressed in psoriatic epidermis","volume":"110","author":"Kulke","year":"1998","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb0655","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/gut.51.6.818","article-title":"Colonic epithelial cells are a major site of macrophage inflammatory protein 3alpha (MIP-3alpha) production in normal colon and inflammatory bowel disease","volume":"51","author":"Kwon","year":"2002","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb0660","first-page":"355","article-title":"Immunology of inflammatory bowel diseases","volume":"87","author":"Lakatos","year":"2000","journal-title":"Acta Physiol Hung"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb0665","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0303-8467(02)00033-1","article-title":"Mechanisms of demyelination and tissue destruction in multiple sclerosis","volume":"104","author":"Lassmann","year":"2002","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb0670","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1172\/JCI15555","article-title":"Decreased atherosclerosis in CX3CR1\u2212\/\u2212 mice reveals a role for fractalkine in atherogenesis","volume":"111","author":"Lesnik","year":"2003","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb0675","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.it.2004.03.006","article-title":"Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and \u201ctype 1\u201d inflammatory gene expression","volume":"25","author":"Lew","year":"2004","journal-title":"Trends Immunol"},{"issue":"5","key":"10.1016\/j.pharmthera.2011.06.008_bb0680","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.clindermatol.2007.11.002","article-title":"Targeting leukocyte recruitment in the treatment of psoriasis","volume":"26","author":"Li","year":"2008","journal-title":"Clin Dermatol"},{"issue":"25","key":"10.1016\/j.pharmthera.2011.06.008_bb0685","doi-asserted-by":"crossref","first-page":"19000","DOI":"10.1074\/jbc.M001222200","article-title":"Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1","volume":"275","author":"Liang","year":"2000","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0690","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4049\/jimmunol.162.1.186","article-title":"CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha","volume":"162","author":"Liao","year":"1999","journal-title":"J Immunol"},{"issue":"6917","key":"10.1016\/j.pharmthera.2011.06.008_bb0695","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0700","doi-asserted-by":"crossref","first-page":"456S","DOI":"10.1093\/ajcn\/83.2.456S","article-title":"Inflammation and cardiovascular disease mechanisms","volume":"83","author":"Libby","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0705","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/jcp.21839","article-title":"CCL20\/CCR6 chemokine\/receptor expression in bone tissue from osteoarthritis and rheumatoid arthritis patients: different response of osteoblasts in the two groups","volume":"221","author":"Lisignoli","year":"2009","journal-title":"J Cell Physiol"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb0710","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nn.2491","article-title":"CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis","volume":"13","author":"Liu","year":"2010","journal-title":"Nat Neurosci"},{"issue":"27","key":"10.1016\/j.pharmthera.2011.06.008_bb0715","doi-asserted-by":"crossref","first-page":"9074","DOI":"10.1523\/JNEUROSCI.1238-10.2010","article-title":"Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells","volume":"30","author":"Liu","year":"2010","journal-title":"J Neurosci"},{"issue":"7","key":"10.1016\/j.pharmthera.2011.06.008_bb0720","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.4049\/jimmunol.176.7.4399","article-title":"Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3\u2212\/\u2212 mice with experimental autoimmune encephalomyelitis","volume":"176","author":"Liu","year":"2006","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb0725","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1471-4892(03)00069-9","article-title":"Chemokines in allergic airway disease","volume":"3","author":"Lloyd","year":"2003","journal-title":"Curr Opin Pharmacol"},{"issue":"11","key":"10.1016\/j.pharmthera.2011.06.008_bb0730","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nrd2358","article-title":"Novel therapeutic strategies for multiple sclerosis\u2014a multifaceted adversary","volume":"7","author":"Lopez-Diego","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"7130","key":"10.1016\/j.pharmthera.2011.06.008_bb0735","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0740","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1600-0625.1999.tb00347.x","article-title":"Structural changes of human epidermis induced by human leukocyte-derived proteases","volume":"8","author":"Ludolph-Hauser","year":"1999","journal-title":"Exp Dermatol"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb0745","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0002-9440(10)62562-X","article-title":"AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity","volume":"160","author":"Lukacs","year":"2002","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.pharmthera.2011.06.008_bb0750","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199802123380706","article-title":"Chemokines\u2013chemotactic cytokines that mediate inflammation","volume":"338","author":"Luster","year":"1998","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0755","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/84205","article-title":"Chemokines as regulators of T cell differentiation","volume":"2","author":"Luther","year":"2001","journal-title":"Nat Immunol"},{"issue":"8","key":"10.1016\/j.pharmthera.2011.06.008_bb0760","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1172\/JCI6993","article-title":"Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells","volume":"104","author":"Mach","year":"1999","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0765","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1191\/1352458503ms899oa","article-title":"Longitudinal study of chemokine receptor expression on peripheral lymphocytes in multiple sclerosis: CXCR3 upregulation is associated with relapse","volume":"9","author":"Mahad","year":"2003","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb0770","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/cs0820273","article-title":"Enhanced synthesis of neutrophil-activating peptide-1\/interleukin-8 in active ulcerative colitis","volume":"82","author":"Mahida","year":"1992","journal-title":"Clin Sci"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2011.06.008_bb0775","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0165-5728(02)00121-2","article-title":"Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist met-RANTES","volume":"128","author":"Matsui","year":"2002","journal-title":"J Neuroimmunol"},{"issue":"7","key":"10.1016\/j.pharmthera.2011.06.008_bb0780","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.4049\/jimmunol.170.7.3461","article-title":"IL-9 enhances the growth of human mast cell progenitors under stimulation with stem cell factor","volume":"170","author":"Matsuzawa","year":"2003","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb0785","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.tins.2005.01.006","article-title":"Multiple sclerosis: novel perspectives on newly forming lesions","volume":"28","author":"Matute","year":"2005","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2011.06.008_bb0790","series-title":"Digestive Disease Week, New Orleans, Louisiana, USA, May 1\u20135 2010 Abstract #711a","article-title":"A randomized placebo-controlled trial of MDX-1100, an anti-IP-10 antibody, for moderately-to-severely active ulcerative colitis","author":"Mayere","year":"2010"},{"issue":"5","key":"10.1016\/j.pharmthera.2011.06.008_bb0795","first-page":"997","article-title":"Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation","volume":"144","author":"Mazzucchelli","year":"1994","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0800","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0165-5728(98)00002-2","article-title":"MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study","volume":"86","author":"McManus","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.pharmthera.2011.06.008_bb0805","unstructured":"Meyer Dos Santos, S., Klinkhardt, U., Scholich, K., Nelson, K., Monsefi, N., Deckmyn, H., et al. (in press). The CX3C chemokine fractalkine mediates platelet adhesion via the von Willebrand receptor glycoprotein ib (GPIb). Blood."},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0810","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1124\/jpet.108.141085","article-title":"Blockade of CXCL12\/CXCR4 axis ameliorates murine experimental colitis","volume":"327","author":"Mikami","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0815","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.bbrc.2009.12.025","article-title":"Pharmacological targeting reveals distinct roles for CXCR2\/CXCR1 and CCR2 in a mouse model of arthritis","volume":"391","author":"Min","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb0820","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2249.1994.tb06047.x","article-title":"IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and crohn's disease","volume":"96","author":"Mitsuyama","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.pharmthera.2011.06.008_bb0825","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.4049\/jimmunol.179.12.8463","article-title":"Blockade of chemokine receptor CXCR3 inhibits T cell recruitment to inflamed joints and decreases the severity of adjuvant arthritis","volume":"179","author":"Mohan","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2011.06.008_bb0830","doi-asserted-by":"crossref","first-page":"297645","DOI":"10.1155\/2009\/297645","article-title":"Interleukin-23 and Th17 cells in the control of gut inflammation","volume":"2009","author":"Monteleone","year":"2009","journal-title":"Mediators Inflamm"},{"issue":"5","key":"10.1016\/j.pharmthera.2011.06.008_bb0835","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1183\/09031936.98.12051067","article-title":"Neutrophil chemokines in bronchoalveolar lavage fluid and leukocyte-conditioned medium from nonsmokers and smokers","volume":"12","author":"Morrison","year":"1998","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0840","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.it.2003.12.005","article-title":"Chemokines: multiple levels of leukocyte migration control","volume":"25","author":"Moser","year":"2004","journal-title":"Trends Immunol"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0845","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0031-6997(24)01439-X","article-title":"International union of pharmacology. XXII. Nomenclature for chemokine receptors","volume":"52","author":"Murphy","year":"2000","journal-title":"Pharmacol Rev"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb0850","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/1521-4141(200206)32:6<1784::AID-IMMU1784>3.0.CO;2-R","article-title":"Neutralization of IFN-inducible protein 10\/CXCL10 exacerbates experimental autoimmune encephalomyelitis","volume":"32","author":"Narumi","year":"2002","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb0855","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1172\/JCI115411","article-title":"Monocyte chemoattractant protein-1 in human atheromatous plaques","volume":"88","author":"Nelken","year":"1991","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb0860","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/1874467211003030145","article-title":"Tumor necrosis factor blockade for treatment of inflammatory bowel disease: efficacy and safety","volume":"3","author":"Ngo","year":"2010","journal-title":"Curr Mol Pharmacol"},{"issue":"8","key":"10.1016\/j.pharmthera.2011.06.008_bb0865","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.4049\/jimmunol.181.8.5386","article-title":"XCL1 enhances regulatory activities of CD4+ CD25(high) CD127(low\/-) T cells in human allergic asthma","volume":"181","author":"Nguyen","year":"2008","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb0870","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jaci.2008.11.037","article-title":"Selective deregulation in chemokine signaling pathways of CD4+CD25(hi)CD127(lo)\/(\u2212) regulatory T cells in human allergic asthma","volume":"123","author":"Nguyen","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.pharmthera.2011.06.008_bb0875","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1172\/JCI200422147","article-title":"Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities","volume":"113","author":"Nickoloff","year":"2004","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb0880","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.clindermatol.2007.08.011","article-title":"The cytokine and chemokine network in psoriasis","volume":"25","author":"Nickoloff","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.pharmthera.2011.06.008_bb0885","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1465-9921-9-82","article-title":"Attenuation of acute lung inflammation induced by cigarette smoke in CXCR3 knockout mice","volume":"9","author":"Nie","year":"2008","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmthera.2011.06.008_bb0890","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1749-6632.2009.04738.x","article-title":"Chemokines as novel therapeutic targets for inflammatory bowel disease","volume":"1173","author":"Nishimura","year":"2009","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb0895","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jaci.2003.08.049","article-title":"Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis","volume":"112","author":"Nomura","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0900","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/gene.2009.82","article-title":"Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis","volume":"11","author":"Ockinger","year":"2010","journal-title":"Genes Immun"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0905","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/(SICI)1096-9896(199705)182:1<106::AID-PATH816>3.0.CO;2-A","article-title":"The role of monocyte chemoattractant protein-1 (MCP-1) in the pathogenesis of collagen-induced arthritis in rats","volume":"182","author":"Ogata","year":"1997","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0910","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/labinvest.3700189","article-title":"Accumulation of CCR5+ T cells around RANTES+ granulomas in crohn's disease: a pivotal site of Th1-shifted immune response?","volume":"85","author":"Oki","year":"2005","journal-title":"Lab Invest"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb0915","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/1568010033483990","article-title":"Stem cell factor: a hemopoietic cytokine with important targets in asthma","volume":"2","author":"Oliveira","year":"2003","journal-title":"Curr Drug Targets Inflamm Allergy"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0920","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/ATVBAHA.109.198812","article-title":"Pharmacological inhibition of C-C chemokine receptor 2 decreases macrophage infiltration in the aortic root of the human C-C chemokine receptor 2\/apolipoprotein E\u2212\/\u2212 mouse: magnetic resonance imaging assessment","volume":"30","author":"Olzinski","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Pt 5","key":"10.1016\/j.pharmthera.2011.06.008_bb0925","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/brain\/awh479","article-title":"CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis","volume":"128","author":"Omari","year":"2005","journal-title":"Brain"},{"issue":"4 Pt 1","key":"10.1016\/j.pharmthera.2011.06.008_bb0930","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1164\/ajrccm.161.4.9812061","article-title":"Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: clinical and biologic significance","volume":"161","author":"Ordonez","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2011.06.008_bb0935","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1465-9921-10-38","article-title":"N-alpha-PGP and PGP, potential biomarkers and therapeutic targets for COPD","volume":"10","author":"O'Reilly","year":"2009","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb0940","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.immuni.2008.03.004","article-title":"The biological functions of T helper 17 cell effector cytokines in inflammation","volume":"28","author":"Ouyang","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2011.06.008_bb0945","unstructured":"Overbeek, S. A., Henricks, P. A., Srienc, A. I., Koelink, P. J., de Kruijf, P., Lim, H. D., et al. (in press). N-acetylated proline-glycine-proline induced G-protein dependent chemotaxis of neutrophils is independent of CXCL8 release. Eur J Pharmacol."},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb0950","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1373\/clinchem.2007.097360","article-title":"Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction","volume":"54","author":"Packard","year":"2008","journal-title":"Clin Chem"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb0955","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/sj.bjp.0707263","article-title":"Chemokines and their receptors as potential targets for the treatment of asthma","volume":"151","author":"Palmqvist","year":"2007","journal-title":"Br J Pharmacol"},{"issue":"11","key":"10.1016\/j.pharmthera.2011.06.008_bb0960","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1172\/JCI12655","article-title":"The C\u2013C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics","volume":"107","author":"Panina-Bordignon","year":"2001","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0965","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood-2009-04-216085","article-title":"Evidence for a cross-talk between human neutrophils and Th17 cells","volume":"115","author":"Pelletier","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb0970","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1183\/09031936.04.00102504","article-title":"CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge","volume":"23","author":"Pilette","year":"2004","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.pharmthera.2011.06.008_bb0975","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bbadis.2009.06.004","article-title":"TGF-beta and fibrosis in different organs \u2014 molecular pathway imprints","volume":"1792","author":"Pohlers","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"10.1016\/j.pharmthera.2011.06.008_bb0980","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/01.ATV.0000231527.22762.71","article-title":"Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice","volume":"26","author":"Potteaux","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.pharmthera.2011.06.008_bb0985","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0923-2494(94)80198-3","article-title":"Transfer of CD4+ T cells to C.B-17 SCID mice: a model to study Th1 and Th2 cell differentiation and regulation in vivo","volume":"145","author":"Powrie","year":"1994","journal-title":"Res Immunol"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb0990","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1084\/jem.179.2.589","article-title":"Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity","volume":"179","author":"Powrie","year":"1994","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.pharmthera.2011.06.008_bb0995","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/1074-7613(94)90045-0","article-title":"Inhibition of Th1 responses prevents inflammatory bowel disease in SCID mice reconstituted with CD45RBhi CD4+ T cells","volume":"1","author":"Powrie","year":"1994","journal-title":"Immunity"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2011.06.008_bb1000","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jneuroim.2008.04.007","article-title":"The use of chemokine antagonists in EAE models","volume":"198","author":"Proudfoot","year":"2008","journal-title":"J Neuroimmunol"},{"issue":"2 Suppl.","key":"10.1016\/j.pharmthera.2011.06.008_bb1005","doi-asserted-by":"crossref","first-page":"S486","DOI":"10.1067\/mai.2003.120","article-title":"4. IgE, mast cells, basophils, and eosinophils","volume":"111","author":"Prussin","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb1010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2036.2004.02262.x","article-title":"A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease","volume":"21","author":"Puleston","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.pharmthera.2011.06.008_bb1015","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1164\/rccm.200208-794OC","article-title":"Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease","volume":"168","author":"Qiu","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb1020","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1172\/JCI200420126","article-title":"Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis","volume":"113","author":"Quinones","year":"2004","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.pharmthera.2011.06.008_bb1025","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1136\/gut.34.9.1203","article-title":"Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis","volume":"34","author":"Raab","year":"1993","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb1030","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"176","author":"Rabe","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb1035","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1046\/j.1365-2133.2001.04219.x","article-title":"Cellular localization of fractalkine at sites of inflammation: antigen-presenting cells in psoriasis express high levels of fractalkine","volume":"144","author":"Raychaudhuri","year":"2001","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb1040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/000155599750011615","article-title":"Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis","volume":"79","author":"Raychaudhuri","year":"1999","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb1045","doi-asserted-by":"crossref","first-page":"G829","DOI":"10.1152\/ajpgi.2000.278.6.G829","article-title":"Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(\u2212\/\u2212) mice and intestinal inflammation","volume":"278","author":"Rennick","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"7","key":"10.1016\/j.pharmthera.2011.06.008_bb1050","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1179\/016164109X12445616596247","article-title":"Circulating interleukin-15 and RANTES chemokine in MS patients: effect of treatment with methylprednisolone in patients with relapse","volume":"32","author":"Rentzos","year":"2010","journal-title":"Neurol Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb1055","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/rheumatology\/keq337","article-title":"CXCL13: a novel biomarker of B-cell return following rituximab treatment and synovitis in patients with rheumatoid arthritis","volume":"50","author":"Rosengren","year":"2011","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.pharmthera.2011.06.008_bb1060","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1002\/1521-4141(2000)30:8<2372::AID-IMMU2372>3.0.CO;2-D","article-title":"Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent","volume":"30","author":"Rottman","year":"2000","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb1065","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/labinvest.3780242","article-title":"Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris","volume":"81","author":"Rottman","year":"2001","journal-title":"Lab Invest"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb1070","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1164\/ajrccm.160.2.9812020","article-title":"CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease","volume":"160","author":"Saetta","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"3 Pt 1","key":"10.1016\/j.pharmthera.2011.06.008_bb1075","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1164\/ajrccm.157.3.9709027","article-title":"CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease","volume":"157","author":"Saetta","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.pharmthera.2011.06.008_bb1080","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1164\/rccm.2107139","article-title":"Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease","volume":"165","author":"Saetta","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb1085","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1161\/CIRCRESAHA.107.170241","article-title":"Open sesame! CXCR4 blockade recruits neutrophils into the plaque","volume":"102","author":"Sainz","year":"2008","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb1090","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/bega.2002.0345","article-title":"Strategies for targeting tumour necrosis factor in IBD","volume":"17","author":"Sandborn","year":"2003","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb1095","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.gastro.2006.10.010","article-title":"Enhanced recruitment of CX3CR1+ T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease","volume":"132","author":"Sans","year":"2007","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb1100","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.nurt.2007.07.004","article-title":"Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce?","volume":"4","author":"Savarin-Vuaillat","year":"2007","journal-title":"Neurotherapeuticss"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb1105","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1084\/jem.20061405","article-title":"CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells","volume":"204","author":"Schneider","year":"2007","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.pharmthera.2011.06.008_bb1110","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1096\/fj.02-0193fje","article-title":"Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4\u2212\/\u2212 mice","volume":"16","author":"Schuh","year":"2002","journal-title":"FASEB J"},{"issue":"5","key":"10.1016\/j.pharmthera.2011.06.008_bb1115","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jaci.2005.07.015","article-title":"The role of T regulatory cells in asthma","volume":"116","author":"Seroogy","year":"2005","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.pharmthera.2011.06.008_bb1120","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.4049\/jimmunol.0901942","article-title":"IL-17-mediated monocyte migration occurs partially through CC chemokine ligand 2\/monocyte chemoattractant protein-1 induction","volume":"184","author":"Shahrara","year":"2010","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb1125","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/art.21033","article-title":"Amelioration of rat adjuvant-induced arthritis by met-RANTES","volume":"52","author":"Shahrara","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb1130","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-5728(97)00208-7","article-title":"Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions","volume":"84","author":"Simpson","year":"1998","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb1135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/187153007780832109","article-title":"CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication","volume":"7","author":"Singh","year":"2007","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb1140","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4049\/jimmunol.180.1.214","article-title":"Human T cells that are able to produce IL-17 express the chemokine receptor CCR6","volume":"180","author":"Singh","year":"2008","journal-title":"J Immunol"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2011.06.008_bb1145","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejphar.2005.12.064","article-title":"A closer look at chemokines and their role in asthmatic responses","volume":"533","author":"Smit","year":"2006","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb1150","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1172\/JCI5150","article-title":"Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients","volume":"103","author":"Sorensen","year":"1999","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.pharmthera.2011.06.008_bb1155","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ni805","article-title":"Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP","volume":"3","author":"Soumelis","year":"2002","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb1160","doi-asserted-by":"crossref","first-page":"L514","DOI":"10.1152\/ajplung.00317.2004","article-title":"Characterization of cigarette smoke-induced inflammatory and mucus hypersecretory changes in rat lung and the role of CXCR2 ligands in mediating this effect","volume":"288","author":"Stevenson","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"10.1016\/j.pharmthera.2011.06.008_bb1165","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0092-8674(00)81539-1","article-title":"The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration","volume":"99","author":"Streblow","year":"1999","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb1170","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1183\/09031936.00111507","article-title":"A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation","volume":"31","author":"Suzaki","year":"2008","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb1175","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-0404.2006.00749.x","article-title":"Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies","volume":"115","author":"Szczucinski","year":"2007","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"10.1016\/j.pharmthera.2011.06.008_bb1180","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.berh.2006.06.001","article-title":"Chemokine inhibition in inflammatory arthritis","volume":"20","author":"Tak","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.pharmthera.2011.06.008_bb1185","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1002\/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V","article-title":"The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis","volume":"43","author":"Tak","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb1190","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1164\/ajrccm.163.6.9908135","article-title":"Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD)","volume":"163","author":"Takizawa","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb1195","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cyto.2009.05.009","article-title":"CCL20 produced in the cytokine network of rheumatoid arthritis recruits CCR6+ mononuclear cells and enhances the production of IL-6","volume":"47","author":"Tanida","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.pharmthera.2011.06.008_bb1200","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.0105-2896.2005.00286.x","article-title":"Defects in mucosal immunity leading to ulcerative colitis","volume":"206","author":"Targan","year":"2005","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb1205","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/01.ATV.14.1.47","article-title":"Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity","volume":"14","author":"Terkeltaub","year":"1994","journal-title":"Arterioscler Thromb"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb1210","doi-asserted-by":"crossref","first-page":"L322","DOI":"10.1152\/ajplung.00039.2005","article-title":"Role of CXCR2 in cigarette smoke-induced lung inflammation","volume":"289","author":"Thatcher","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb1215","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/71908","article-title":"Resolution of cutaneous inflammation after local elimination of macrophages","volume":"18","author":"Thepen","year":"2000","journal-title":"Nat Biotechnol"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb1220","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.bbrc.2006.03.159","article-title":"Intestinal neuro-epithelial interactions modulate neuronal chemokines production","volume":"344","author":"Tixier","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10.1016\/j.pharmthera.2011.06.008_bb1225","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1111\/j.1462-5822.2005.00596.x","article-title":"Human mucosa\/submucosa interactions during intestinal inflammation: involvement of the enteric nervous system in interleukin-8 secretion","volume":"7","author":"Tixier","year":"2005","journal-title":"Cell Microbiol"},{"issue":"8","key":"10.1016\/j.pharmthera.2011.06.008_bb1230","doi-asserted-by":"crossref","DOI":"10.1093\/intimm\/dxh284","article-title":"The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis","volume":"17","author":"Tokuyama","year":"2005","journal-title":"Int Immunol"},{"issue":"7","key":"10.1016\/j.pharmthera.2011.06.008_bb1235","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/thorax.57.7.590","article-title":"Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD","volume":"57","author":"Traves","year":"2002","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb1240","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1189\/jlb.1003495","article-title":"Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2","volume":"76","author":"Traves","year":"2004","journal-title":"J Leukoc Biol"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb1245","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tips.2005.11.002","article-title":"The expression and function of chemokines involved in CNS inflammation","volume":"27","author":"Ubogu","year":"2006","journal-title":"Trends Pharmacol Sci"},{"issue":"95","key":"10.1016\/j.pharmthera.2011.06.008_bb1250","first-page":"211","article-title":"Understanding the immunological basis of asthma; immunotherapy and regulatory T cells","volume":"95","author":"Umetsu","year":"2006","journal-title":"Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M"},{"key":"10.1016\/j.pharmthera.2011.06.008_bb1255","unstructured":"van de Veerdonk, F. L., Lauwerys, B., Marijnissen, R. J., Timmermans, K., Di Padova, F., Koenders, M. I., et al. (in press). The anti-CD20 antibody rituximab reduces the T helper 17 response. Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb1260","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0002-9440(10)65249-2","article-title":"Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions","volume":"154","author":"Van Der Voorn","year":"1999","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.pharmthera.2011.06.008_bb1265","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1136\/ard.2010.131235","article-title":"CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trial","volume":"69","author":"van Kuijk","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb1270","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/ATVBAHA.107.147827","article-title":"CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice","volume":"28","author":"van Wanrooij","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.pharmthera.2011.06.008_bb1275","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1161\/01.ATV.0000192018.90021.c0","article-title":"HIV entry inhibitor TAK-779 attenuates atherogenesis in low-density lipoprotein receptor-deficient mice","volume":"25","author":"van Wanrooij","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb1280","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/01.RES.0000109793.17591.4E","article-title":"Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice","volume":"94","author":"Veillard","year":"2004","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb1285","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/CIRCULATIONAHA.104.520718","article-title":"Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo","volume":"112","author":"Veillard","year":"2005","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.pharmthera.2011.06.008_bb1290","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/art.23591","article-title":"Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial","volume":"58","author":"Vergunst","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.pharmthera.2011.06.008_bb1295","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1002\/art.24978","article-title":"MLN3897 plus methotrexate in patients with rheumatoid arthritis: safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study","volume":"60","author":"Vergunst","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb1300","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1124\/jpet.107.134783","article-title":"Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptors","volume":"325","author":"Verzijl","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb1305","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/art.20850","article-title":"Inhibition of the development of collagen-induced arthritis in rhesus monkeys by a small molecular weight antagonist of CCR5","volume":"52","author":"Vierboom","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pharmthera.2011.06.008_bb1310","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev.pharmtox.48.121806.154841","article-title":"Chemokines and their receptors: drug targets in immunity and inflammation","volume":"48","author":"Viola","year":"2008","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb1315","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood-2004-06-2475","article-title":"Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium","volume":"105","author":"von Hundelshausen","year":"2005","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.pharmthera.2011.06.008_bb1320","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1161\/01.CIR.103.13.1772","article-title":"RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium","volume":"103","author":"von Hundelshausen","year":"2001","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.pharmthera.2011.06.008_bb1325","doi-asserted-by":"crossref","first-page":"8837","DOI":"10.1074\/jbc.271.15.8837","article-title":"Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma","volume":"271","author":"Wang","year":"1996","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb1330","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nm1361","article-title":"A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation","volume":"12","author":"Weathington","year":"2006","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.pharmthera.2011.06.008_bb1335","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/nri2415","article-title":"The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models","volume":"8","author":"Weber","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb1340","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tips.2005.11.001","article-title":"Chemokine blockers\u2014therapeutics in the making?","volume":"27","author":"Wells","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2011.06.008_bb1345","unstructured":"Wermers, J. D., McNamee, E. N., Wurbel, M. A., Jedlicka, P., & Rivera-Nieves, J. (in press). The chemokine receptor CCR9 is required for the T-cell-mediated regulation of chronic ileitis in mice. Gastroenterology."},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb1350","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/cvr\/cvp341","article-title":"Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling","volume":"85","author":"White","year":"2010","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb1355","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/WCO.0b013e3280be58d8","article-title":"Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis","volume":"20","author":"Wingerchuk","year":"2007","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb1360","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1054-8807(02)00111-4","article-title":"Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease","volume":"11","author":"Wong","year":"2002","journal-title":"Cardiovasc Pathol"},{"issue":"8","key":"10.1016\/j.pharmthera.2011.06.008_bb1365","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1172\/JCI118989","article-title":"Dermal injection of immunocytes induces psoriasis","volume":"98","author":"Wrone-Smith","year":"1996","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.pharmthera.2011.06.008_bb1370","doi-asserted-by":"crossref","first-page":"e16442","DOI":"10.1371\/journal.pone.0016442","article-title":"CCL25\/CCR9 interactions regulate large intestinal inflammation in a murine model of acute colitis","volume":"6","author":"Wurbel","year":"2011","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.pharmthera.2011.06.008_bb1375","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.3748\/wjg.v16.i23.2873","article-title":"CXCR4 antagonist AMD3100 attenuates colonic damage in mice with experimental colitis","volume":"16","author":"Xia","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb1380","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1378\/chest.07-0569","article-title":"Overexpression of CD-11b and CXCR1 on circulating neutrophils: its possible role in COPD","volume":"132","author":"Yamagata","year":"2007","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb1385","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1378\/chest.112.2.505","article-title":"Airway inflammation in COPD assessed by sputum levels of interleukin-8","volume":"112","author":"Yamamoto","year":"1997","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb1390","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/jlb.66.3.401","article-title":"Fully human anti-interleukin-8 monoclonal antibodies: potential therapeutics for the treatment of inflammatory disease states","volume":"66","author":"Yang","year":"1999","journal-title":"J Leukoc Biol"},{"issue":"8","key":"10.1016\/j.pharmthera.2011.06.008_bb1395","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/1521-4141(200208)32:8<2124::AID-IMMU2124>3.0.CO;2-S","article-title":"A non-peptide CCR5 antagonist inhibits collagen-induced arthritis by modulating T cell migration without affecting anti-collagen T cell responses","volume":"32","author":"Yang","year":"2002","journal-title":"Eur J Immunol"},{"issue":"11","key":"10.1016\/j.pharmthera.2011.06.008_bb1400","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.4049\/jimmunol.163.11.6321","article-title":"Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C\u2013C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics","volume":"163","author":"Ying","year":"1999","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.pharmthera.2011.06.008_bb1405","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1002\/eji.1830271252","article-title":"Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells","volume":"27","author":"Ying","year":"1997","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.pharmthera.2011.06.008_bb1410","first-page":"321","article-title":"How much do we know about atopic asthma: where are we now?","volume":"3","author":"Ying","year":"2006","journal-title":"Cell Mol Immunol"},{"issue":"12","key":"10.1016\/j.pharmthera.2011.06.008_bb1415","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1073\/pnas.88.12.5252","article-title":"Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions","volume":"88","author":"Yla-Herttuala","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.pharmthera.2011.06.008_bb1420","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.20062076","article-title":"CCR4-dependent regulatory T cell function in inflammatory bowel disease","volume":"204","author":"Yuan","year":"2007","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb1425","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/sj.gene.6363673","article-title":"CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis","volume":"1","author":"Zapico","year":"2000","journal-title":"Genes Immun"},{"issue":"2","key":"10.1016\/j.pharmthera.2011.06.008_bb1430","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/CIRCRESAHA.107.160697","article-title":"Protective role of CXC receptor 4\/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis","volume":"102","author":"Zernecke","year":"2008","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.pharmthera.2011.06.008_bb1435","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1161\/ATVBAHA.107.161174","article-title":"Chemokines in atherosclerosis: an update","volume":"28","author":"Zernecke","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.pharmthera.2011.06.008_bb1440","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0016-5085(97)70175-6","article-title":"The C\u2013X\u2013C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease","volume":"113","author":"Z'Graggen","year":"1997","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.pharmthera.2011.06.008_bb1445","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1744-313X.2010.00920.x","article-title":"Genome-wide haplotype association analysis and gene prioritization identify CCL3 as a risk locus for rheumatoid arthritis","volume":"37","author":"Zhang","year":"2010","journal-title":"Int J Immunogenet"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725811001628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725811001628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T02:45:45Z","timestamp":1741401945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725811001628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":289,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0163725811001628"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2011.06.008","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}